Condition: Colorectal Cancer · Sponsor: ADVANCED MARKER DISCOVERY S.L.
The objective of this observational study is to evaluate the false positive rate of the blood test based on molecular biomarkers and risk factors. A total of 250 patients diagnosed with various cancers and gastrointestinal diseases will be enrolled. The main question to be answered is Does the blood test have a low false positive rate in the main study population? Participants will donate a blood sample as part of their regular medical care for cancer diagnosis and give the consent to know their clinical risk factors.
This description comes directly from the study's public registry record.
Marta Jimenez · +34637899149 · mjimenez@amadix.com
Always discuss trial participation with your own doctor first.
| Hospitales HM de Malaga | Málaga, Andalusia, Spain | Recruiting |
| Hospital Centro Médico Asturias | Oviedo, Cantabria, Spain | Recruiting |
| Hospital Universitario de Ourense | Ourense, Galicia, Spain | Recruiting |
| Hospital Universitario HM Sanchinarro | Madrid, Madrid, Spain | Recruiting |
| MD Anderson Cancer Centre | Madrid, Madrid, Spain | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06889844